Home / Inspections / 1020761

FDA Inspection 1020761 — Lilly del Caribe, Inc

Lilly del Caribe, Inc — FEI 2619243

The FDA completed an inspection of Lilly del Caribe, Inc on July 21, 2017 in Carolina, PR. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
July 21, 2017
Fiscal Year
2017
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Carolina, PR (United States)

Facility

Other inspections at this facility

  • 1300794 (VAI Fri Jan 30 2026 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1163359 (VAI Fri Feb 25 2022 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1097298 (VAI Fri Jul 12 2019 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1069938 (VAI Fri Sep 21 2018 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 927312 (NAI Fri May 01 2015 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources